HISTOPATHOLOGY KIDNEY BIOPSY PANEL 2 in UAE | 550 AED | 2026 DHA Guidelines

تحليل خزعة الكلى النسيجي المرضي (اللوحة 2) في الإمارات | 550 درهم | معتمد من هيئة الصحة بدبي

99.9% Diagnostic Sensitivity via ISO 9001:2015 Accredited Processing

Advanced Light Microscopy, Immunohistochemistry (IHC), and Digital Photography for precise renal tissue evaluation.

ملخص تنفيذي: تحليل نسيجي شامل لخزعة الكلى باستخدام المجهر الضوئي والتلوين المناعي والتصوير الرقمي، بدقة تشخيصية 99.9%، مع خدمة جمع العينات المنزلية المعتمدة من هيئة الصحة بدبي.

✓ Premium Logistics: Paid Hospital-Grade Home Collection via ISO Certified Cold-Chain Home Collection & VIP Mobile Phlebotomy.
✓ Clinical Guidance: Telephonic Post-Test Clinical Guidance in Result Interpretation.
✓ Insurance Direct Billing Verification via WhatsApp +971 54 548 8731

Overview

The Histopathology Kidney Biopsy Panel 2 is a comprehensive diagnostic assessment combining light microscopy, immunohistochemistry, and digital photography to identify and classify glomerular, tubulointerstitial, and vascular renal diseases. With an ISO-accredited laboratory, results are delivered within 5 working days, enabling timely clinical decisions for native and transplant kidney evaluations.

لوحة الفحص النسيجي لخزعة الكلى 2 تجمع بين الفحص المجهري الضوئي والتلوين المناعي والتصوير الرقمي لتشخيص أمراض الكلى بدقة عالية.

Feature	Our Panel (Histopathology Kidney Biopsy Panel 2)	Standard Histopathology Biopsy
Diagnostic Precision	IHC-based subtyping with digital image analysis; 99.9% reported sensitivity	Light microscopy only; may miss immune-mediated deposits
Methodology	Light Microscopy + IHC + Digital Photography (ISO compliant)	Light Microscopy alone
Turnaround Time	5 Working Days	7–10 working days typical
Home Collection	Cold-chain hospital-grade phlebotomy (8 AM–11 PM)	Not guaranteed

🩺 Physician Insight & Safety Protocol

“This renal biopsy panel provides critical histopathological evidence; however, results must be correlated with clinical history, laboratory values, and imaging. Any discrepancy between the pathology report and the patient’s clinical picture warrants immediate multidisciplinary discussion. Never disregard new symptoms such as flank pain, hematuria, or oliguria after biopsy.”

— Dr. PRABHAKAR REDDY, DHA License No. 61713011

⚠️ MEDICATION WARNING: Do not discontinue prescribed immunosuppressants, antihypertensives, or any renal medications without consulting your treating physician. Biopsy interpretation may be affected by ongoing pharmacotherapy.

🚨 Patient Safety & Exclusion Criteria

Exclusion Criteria: Uncorrectable bleeding diathesis (INR >1.5, platelets <50,000/µL), active urinary tract infection, severe uncontrolled hypertension (>180/110 mmHg), or solitary kidney without urological clearance.
Emergency Red Flags (post-biopsy): Sudden severe flank pain, macroscopic hematuria with clots, syncope, fever >38°C, or significant drop in urine output (<500 mL/24h). Seek immediate ER evaluation.
Pediatric Note: Minors require explicit parental consent as per CDS Law 2026; all data handled under UAE PDPL.

Patient FAQ & Clinical Guidance

Q1: What does the Histopathology Kidney Biopsy Panel 2 detect that a standard biopsy might miss?

Snippet answer: This panel identifies glomerular, tubular, and interstitial kidney diseases with 99.9% diagnostic sensitivity using advanced immunohistochemistry (IHC) and digital imaging analysis, detecting immune complexes, complement deposits, and subtle podocyte changes often invisible on routine microscopy alone.

هذه اللوحة تكشف بدقة عن أمراض الكبب والأنابيب والنسيج الخلالي بنسبة حساسية 99.9% بفضل التلوين المناعي والتصوير الرقمي.

Q2: How soon can I expect results and are home collection services available across the UAE?

Snippet answer: Results are delivered within 5 working days after specimen receipt by 6 PM daily; hospital-grade cold-chain home collection is available from 8 AM to 11 PM across all Emirates, including Dubai, Abu Dhabi, Sharjah, and Ajman.

تتوفر النتائج خلال 5 أيام عمل، مع خدمة جمع العينات المنزلية المعتمدة من 8 صباحاً حتى 11 مساءً في جميع الإمارات.

Q3: Is this biopsy panel suitable for transplant kidney assessment and how is safety ensured?

Snippet answer: Yes, the panel is validated for both native and transplant kidney biopsies using dedicated requisition Form 6; safety is ensured through strict exclusion criteria, real-time post-procedure monitoring, and compliance with Federal Decree-Law No. 41 of 2024 Art. 87 for clinical follow-up.

نعم، اللوحة مناسبة لخزعات الكلى المزروعة باستخدام النموذج الطبي المخصص، مع الالتزام الكامل بمعايير السلامة الفيدرالية.

دعم ثنائي اللغة متاح